GUFIC BIOSCIENCES: Q2 EBITDA 358M RUPEES VS 386M (YOY) || Q2 EBITDA MARGIN 15.54% VS 18.92% (YOY)

GUFIC BIOSCIENCES: Q2 SL NET PROFIT 149M RUPEES VS 217M (YOY) || Q2 REVENUE 2.3B RUPEES VS 2B (YOY)

N R AGARWAL INDUSTRIES: Q2 SL NET LOSS 15M RUPEES VS PROFIT 83M (YOY) || Q2 REVENUE 5.25B RUPEES VS 4.28B (YOY) || Q2 EBITDA 438M RUPEES VS 469M (YOY) || Q2 EBITDA MARGIN 8.36% VS 6.29% (YOY) || Q2 EXCEPTIONAL ITEM 44M RUPEES

JAI BALAJI INDUSTRIES: Q2 SL NET PROFIT 264.8M RUPEES VS 1.53B (YOY) || Q2 REVENUE 13.53B RUPEES VS 15.56B (YOY) || Q2 EBITDA 719.3M RUPEES VS 2.28B (YOY) || Q2 EBITDA MARGIN 5.31% VS 14.66% (YOY)

J.G.CHEMICALS: Q2 CONS NET PROFIT 144M RUPEES VS 165M (YOY) || Q2 REVENUE 2.2B RUPEES VS 2.12B (YOY) || Q2 EBITDA 179.5M RUPEES VS 211.1M (YOY) || Q2 EBITDA MARGIN 8.15% VS 9.95% (YOY)

SEPC: Q2 CONS NET PROFIT 83M RUPEES VS 23M (YOY) || Q2 REVENUE 2.37B RUPEES VS 1.71B (YOY) || Q2 EBITDA 105.7M RUPEES VS 76.8M (YOY) || Q2 EBITDA MARGIN 4.45% VS 4.49% (YOY)

HERANBA INDUSTRIES: Q2 SL NET PROFIT 320.4M RUPEES VS 339.6M (YOY) || Q2 REVENUE 6.06B RUPEES VS 4.58B (YOY) || Q2 EBITDA 447.1M RUPEES VS 463M (YOY) || Q2 EBITDA MARGIN 7.38% VS 10.12% (YOY)

TRIBHOVANDAS BHIMJI ZAVERI: Q2 EBITDA 631M RUPEES VS 362M (YOY) || Q2 EBITDA MARGIN 9.19% VS 6.39% (YOY)

TRIBHOVANDAS BHIMJI ZAVERI: Q2 SL NET PROFIT 307M RUPEES VS 132M (YOY) || Q2 REVENUE 6.9B RUPEES VS 5.7B (YOY)

OIL INDIA: Q2 SL NET PROFIT 10.44B RUPEES VS 18.34B (QOQ) || Q2 REVENUE 54.57B RUPEES VS 55.2B (QOQ) || Q2 EBITDA 13.25B RUPEES VS 16.06B (QOQ) || Q2 EBITDA MARGIN 24.28% VS 32.05% (QOQ) || CO RECOMMENDED INTERIM DIVIDEND OF 3.5 RUPEES/SHARE

Tata Motors: JLR Executive Expresses Concerns Over China, Notes Luxury Tax Changes Affecting Sales and Demand for Luxury Goods

GLENMARK PHARMA: Q2 EBITDA 23.6B RUPEES VS 6.1B (YOY) || Q2 EBITDA MARGIN 39.03% VS 17.88% (YOY)

GLENMARK PHARMA: Q2 CONS NET PROFIT 6.1B RUPEES VS 3.54B (YOY) || Q2 REVENUE 60.5B RUPEES VS 34B (YOY)

BRAINBEES SOLUTIONS: Q2 EBITDA 622M RUPEES VS 571M (YOY) || Q2 EBITDA MARGIN 2.96% VS 3% (YOY)

BRAINBEES SOLUTIONS: Q2 CONS NET LOSS 351M RUPEES VS LOSS 502M (YOY) || Q2 REVENUE 20.99B RUPEES VS 19B (YOY)

INDIA GLYCOLS: Q2 EBITDA 1.6B RUPEES VS 1.2B (YOY) || Q2 EBITDA MARGIN 6.63% VS 5.6% (YOY)

INDIA GLYCOLS: Q2 CONS NET PROFIT 651M RUPEES VS 497M (YOY) || Q2 REVENUE 24.1B RUPEES VS 21.4B (YOY)